Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: Results from the ESMaestras cohort
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: Results from the ESMaestras cohort
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 134, Issue 6, Pages 1436-1444
Publisher
Wiley
Online
2013-09-05
DOI
10.1002/ijc.28469
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Body size throughout the life course and mammographic density in Mexican women
- (2013) Megan S. Rice et al. BREAST CANCER RESEARCH AND TREATMENT
- Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses’ Health Studies
- (2012) Megan S. Rice et al. BREAST CANCER RESEARCH AND TREATMENT
- Sources of Pre-Analytical Variations in Yield of DNA Extracted from Blood Samples: Analysis of 50,000 DNA Samples in EPIC
- (2012) Elodie Caboux et al. PLoS One
- The association between body shape silhouette and dietary pattern among Mexican women
- (2011) Isabelle Romieu et al. PUBLIC HEALTH NUTRITION
- A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC)
- (2010) Francesca L. Crowe et al. ANNALS OF HUMAN BIOLOGY
- Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density
- (2010) Margarethe Biong et al. BMC Medical Genomics
- Moderate physical activity and breast cancer risk: the effect of menopausal status
- (2010) Angélica Ángeles-Llerenas et al. CANCER CAUSES & CONTROL
- Eighteen Insulin-like Growth Factor Pathway Genes, Circulating Levels of IGF-I and Its Binding Protein, and Risk of Prostate and Breast Cancer
- (2010) F. Gu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium†
- (2010) Federico Canzian et al. HUMAN MOLECULAR GENETICS
- Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies
- (2010) LANCET ONCOLOGY
- Anthropometric Correlates of Insulin-Like Growth Factor 1 (IGF-1) and IGF Binding Protein-3 (IGFBP-3) Levels by Race/Ethnicity and Gender
- (2009) Jessica M. Faupel-Badger et al. ANNALS OF EPIDEMIOLOGY
- IGF-I and IGFBP-3 Polymorphisms in Relation to Circulating Levels among African American and Caucasian Women
- (2009) A. A. D'Aloisio et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Premenopausal Mammographic Density in Relation to Cyclic Variations in Endogenous Sex Hormone Levels, Prolactin, and Insulin-like Growth Factors
- (2009) K. Walker et al. CANCER RESEARCH
- Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations
- (2009) Sana Khoury-Shakour et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies
- (2009) Wensen Chen et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- IGF1, IGFBP1, and IGFBP3 genes and mammographic density: The Multiethnic Cohort
- (2009) Martijn Verheus et al. INTERNATIONAL JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started